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A novel redox-responsive PEG-sheddable copolymer of disulfide-linked polyethylene glycol
5000-lysine-di-tocopherol succinate (P5kSSLV) was designed and synthesized. Thin-film
hydration method was used to prepare DOX-loaded P5kSSLV nanomicelle. To optimize
the preparation technology, we investigate the effects of dosage, type of organic solvent,
hydration temperature and time, and cryoprotectant on drug-loading content, encapsu-
lation efficiency, particle size, and zeta potential. The mean particle size and zeta potential
were determined by Zetasizer. The morphology of the P5kSSLV-DOX nanomicelles was
visualized by transmission electron microscopy. The drug-loading content and encapsu-
lation efficiency of P5kSSLV-DOX nanomicelle were investigated by UV. The drug-loading
content, encapsulation efficiency, particle size, and zeta potential of the final optimized
nanomicelles were 4.58%, 97.20%, 30.21 nm and 0.84 mV, respectively. In addition, the
stability of nanomicelles was investigated, which included dilution stability and storage
stability. The results showed that P5kSSLV-DOX nanomicelle had good dilution stability and
storage stability at 4 C. The preparation method of P5kSSLV-DOX nanomicelle with thin-
film hydration method was practical and simple, which was valuable to be further studied.
© 2014 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All
rights reserved.321.
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Many anti-tumor drugs (e.g. paclitaxel, doxorubicin) have
poor solubility in water, which reduces the therapeutic effect
and limits the clinical application. To solve the problem,
many preparation techniques have been explored, such as
emulsions, cyclodextrin inclusion compounds, nano-
suspensions and so on [1]. But the effect is unsatisfactory and
the adverse drug reaction is still serious. Nanomicelle has
become the most promising carrier due to its ability to
improve drug solubility, prolong the circulation time and
target tumor tissue [2].
Nanomicelle is an aggregate composed of amphiphilic di-
or tri-block copolymers, which aggregate into a coreeshell
structure by hydrogen bond, electrostatic interaction and
van der Waals forces among the molecules. Compared with
other drug delivery systems, nanomicelle has some advan-
tageous characteristics: (i) The critical micelle concentration
of nanomicelle is low, which has better thermodynamics
and kinetics stability, and better dilution stability [3]. (ii)
Nanomicelle has a coreeshell structure: the hydrophilic
shell can prevent the absorption with plasma opsonic, and
hydrophobic core can load the insoluble drug. (iii) Nano-
micelle has a small size and narrow particle size distribu-
tion, which can accumulate in tumor via enhanced
permeability and retention (EPR) effect, therefore, has a
better tumor-targeting ability [2, 4]. (iv) The structure of
polymer can be modified with ligands or targets, which can
improve the active targeting property [5e7]. (v) The prepa-
ration is simple, and the nanomicelle is easy to store.
Therefore, nanomicelle has a better prospect in the treat-
ment of cancer.
The preparation of nanomicelle can be classified into two
categories: chemical and physical methods. Chemical
method involves the covalent coupling of the drug to the
polymer, after which the drug was encapsulated into the
core by self-assembly. The preparation process contains a
series of chemical reaction, which can be challenging and
complicated. Thus, most of nanomicelles are prepared
by physical method, which includes direct dissolution
method, dialysis method, self-assembly solvent evaporation
method and thin-film hydration method. The thin-film hy-
dration method is most often used due to its simplicity and
practicability, and its ability to yield small and uniform
particles.
In this study, a novel redox-responsive copolymer of
disulfide-linked polyethylene glycol 5000-lysine-di-tocoph-
erol succinate (P5kSSLV) is designed and synthesized. With
doxorubicin (DOX) as a model drug, DOX-loaded P5kSSLV
(P5kSSLV-DOX) nanomicelle was prepared using thin-film
hydration method. To achieve the optimal prescription, we
investigated the effects of dosage, type of organic solvent,
hydration temperature, hydration time, and cryoprotectant
on drug-loading content, encapsulation efficiency, particle
size, and zeta potential. In addition, we also studied the
stability of the prepared nanomicelle for a month.2. Materials and methods
2.1. Materials
Doxorubicin hydrochloride (DOX$HCl) was purchased from
Beijing Huafeng United Technology Co., Ltd. Triethylamine,
dichloromethane, chloroform, methanol et al. were obtained
from Yuwang Co. Ltd (Shandong, China). N-succinimidyl-3-(2-
pyridyldithiol) propionate (SPDP) and amidoethyoxyl-lysine-
di-tocopherol succinate (amidoethyoxyl-LV) were synthesized
in this laboratory. Methoxy PEG Thiol (mPEG5000-SH, MW 5000)
was obtained from Beijing JENKEM TECHNOLOGY (Beijing,
China).2.2. Synthesis of P5kSSLV copolymer
Amidoethyoxyl-LV was dissolved in dichloromethane and
reacted with SPDP to obtained PDP-LV, Then PDP-LV was
reactedwithmPEG5000-SH in dichloromethane to obtained the
end-product P5kSSLV.2.3. Preparation of P5kSSLV-DOX nanomicelles
20 mg P5kSSLV copolymer, triethylamine and DOX$HCl so-
lution (1 mg/ml in methanol) were dissolved in organic
solvent and were mixed for 1 h. Then the organic solvent
was removed using a rotary vacuum evaporation and was
further dried under a constant flow of nitrogen for 30 min to
form a drug-containing lipid membrane. 1 mL HEPES buffer
solution (HBS, pH 7.4) was added to the drug-containing
lipid membrane and the solution was heated and stirred to
get a preliminary nanomicelle solution. Such nanomicelle
solution was then centrifuged at 13,000 rpm for 20 min, and
the final nanomicelle was obtained by filtering through
0.22 mm filters.2.4. Optimization of thin-film hydration method
2.4.1. Optimization of organic solvent
Nanomicelle was prepared as the method described in 2.2.
The organic solvent was dichloromethane or trichloro-
methane. Then the drug-loading content, encapsulation effi-
ciency and particle size were measured as described.
2.4.2. Optimization of hydration temperature and time
Nanomicelle was prepared as themethod described in section
2.2. The hydration temperature was 25 C, 37 C, 50 C, 60 C
and the hydration timewas 3 h, 4 h, 5 h, 6 h, respectively. Then
P5kSSLV-DOX nanomicelles were evaluated.
2.4.3. Optimization of proportion of DOX and P5kSSLV
Nanomicelle was prepared as the method described in 2.2.
The amount of DOX was 0.5 mg, 1 mg, 2 mg and 3 mg,
respectively. Then P5kSSLV-DOX nanomicelles were
evaluated.
Fig. 1 e Synthetic route of copolymer P5kSSLV.
a s i a n j o u rn a l o f p h a rma c e u t i c a l s c i e n c e s 9 ( 2 0 1 4 ) 2 4 4e2 5 02462.4.4. Optimization of lyoprotectant
The nanomicelle solution was added 5% or 10% of sucrose or
mannitol. Then the particle sizes of nanomicelle solution
were measured before and after freeze-drying.2.5. Drug-loading content (DL) and encapsulation
efficiency (EE)
Ultraviolet-visible light spectrometer was used tomeasure the
DL and EE of P5kSSLV-DOX nanomicelles and the absorption
wavelength was 485 nm. P5kSSLV-DOX nanomicelle solution
was centrifuged for 20 min at 13000 rpm to remove the free
DOX. Then P5kSSLV-DOX nanomicelle solution was diluted
with methanol for 20-fold and was sonicated for 30 min to
disassemble the nanomicelles, which facilitates the encap-
sulated DOX to dissolve. After filtration through a 0.22 mm
filter, the optical absorbance of the solution was measured.
The DOX content was calculated from the calibration curve,
which had a linear range of 15e40 mg/ml. The drug-loading
percentage was defined as the ratio between the amount of
the DOX content and the amount of drug-loaded nano-
micelles. The encapsulation efficiency was calculated as the
percentage of the encapsulated DOX among the total amount
of DOX. The formulas are as follow:
DL% ¼ weight of the drug in nanomicelles/weight of the
feeding copolymer and drug  100
EE% ¼ weight of the drug in nanomicelles/weight of the
feeding drug  100.2.6. Particle size and zeta potential
The particle size and zeta potential of P5kSSLV-DOX nano-
micelles were determined by Zetasizer (Nano ZS, Malvern Co.,
UK). The measurements were repeated three times.2.7. Particle morphology
The morphology of the micelles was characterized using
transmission electron microscope (TEM, H-600, Hitachi,
Japan). Before visualization, diluted dispersions of micelles
were negatively stained with 1% phosphotungstic acid.
2.8. Stability of nanomicelle
2.8.1. Dilution stability
The nanomicelle solution was diluted with phosphate buffer
solution for 10, 100, 1000, 2000 times, respectively. The particle
sizes were measured.
2.8.2. Storage stability
The nanomicelle solution was saved at 4 C. The drug-loading
content, encapsulation efficiency, zeta potential and particle
size were investigated at predetermined time intervals for a
month.3. Results and discussion
3.1. Synthesis of P5kSSLV copolymer
The hydrophilic group mPEG5000 and hydrophobic group ami-
doethyoxyl- lysine-di-tocopherol succinate (amidoethyoxyl-
LV) were linked by disulfide bond crosslinking agent N-succi-
nimidyl-3-(2-pyridyldithiol) propionate (SPDP). SPDP reacted
with amidoethyoxyl-LV firstly and reacted with mPEG5000-SH
secondly. The synthesis route was shown in Fig. 1.
3.2. Preparation of nanomicelles
P5kSSLV copolymer and DOXwere dissolved in organic solvent
after a thorough mixing. Then the organic solvent was
Fig. 2 e Schematic of the self-assembly of P5kSSLV-DOX nanomicelles in aqueous medium and the process of thin-film
hydration method.
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such lipid membrane was dissolved in HBS for the self-
assembly of P5kSSLV-DOX nanomicelles. The driving force of
self-assembly was the hydrophobic effect between the hy-
drophobic segments in the polymer. The hydrophobic effect
also played an important role in the encapsulation of DOX,Table 1 e Optimization of organic solvents.
Solvent Dichloromethane Chloroform
Size (nm) 31.22 ± 2.09 30.57 ± 0.76
DL (%) 4.47 ± 0.03 4.35 ± 0.06
EE (%) 95.42 ± 1.15 95.88 ± 1.8
Data present mean ± standard deviation (n ¼ 3).
Fig. 3 e Encapsulation efficiency of P5kSSLV-DOX
nanomicelles in different hydration temperature and
hydration time.which stabilized the intermolecular interaction between DOX
and the hydrophobic segment. The PEG hydration shell
shielded the DOX against the enzymatic degradation and
phagocytosis in vivo, which would improve drug stability and
therapeutic effect. Fig. 2 showed the schematic of the self-
assembly of P5kSSLV-DOX nanomicelles in aqueous medium
and the process of thin-film hydration method.3.3. Optimization of the preparation conditions for thin-
film hydration
3.3.1. Organic solvent
Organic solvent affects the preparation of nanomicelle
through two aspects. One is the extent of mixing betweenFig. 4 e Drug-loading content of P5kSSLV-DOX
nanomicelles in different hydration temperature and
hydration time.
Table 2 e Optimization of proportion of P5kSSLV and DOX.
Polymer/drug (w/w) Particle size (nm) Zeta potential (mV) EE% DL%
Theoretical value Measured value
20:0.5 31.51 ± 1.88 1.21 ± 0.23 97.31 ± 1.15 2.43 1.19 ± 0.01
20:1 30.21 ± 1.37 0.84 ± 2.25 97.20 ± 1.02 4.76 4.58 ± 0.01
20:2 31.05 ± 0.94 0.60 ± 1.11 91.71 ± 0.86 9.09 8.24 ± 0.04
20:3 30.57 ± 0.86 1.20 ± 0.54 90.14 ± 0.67 13.04 11.30 ± 0.05
Table 3 e Optimization of cryoprotectant.
Cryoprotectant No lyoprotectant Mannitol Sucrose
5% 10% 5% 10%
Particle size (nm) 54.86 ± 15.92 52.96 ± 8.60 42.96 ± 4.59 20.71 ± 1.21 20.92 ± 2.44
a s i a n j o u rn a l o f p h a rma c e u t i c a l s c i e n c e s 9 ( 2 0 1 4 ) 2 4 4e2 5 0248drug and copolymer, the other is the extent of the extension of
copolymer molecules. Usually, organic solvent in thin-film
hydration method is volatile, with chloroform being the
most commonly used. However, due to the strong liver and
renal toxicity of chloroform, we chose dichloromethane as the
organic solvent to investigate the preparation effect in com-
parison with chloroform. Table 1 showed that there were
nearly no differences between dichloromethane and chloro-
form in particle size, drug-loading content and encapsulation
efficiency. For safety concerns, we chose dichloromethane as
the optimal organic solvent.
3.3.2. Hydration temperature and hydration time
The hydration temperature in preparation method was
investigated at 25 C, 37 C, 50 C, 60 C and the hydration time
was 3 h, 4 h, 5 h, 6 h, respectively. Particle sizes of nano-
micelles were similar under different hydration temperatures
and time. So we took the drug-loading content andFig. 5 e Transmission electron microscopy (TEM) image of
P5kSSLV-DOX nanomicelle.encapsulation efficiency as the target to optimize the prepa-
ration technology. As shown in Figs. 3 and 4, the drug-loading
contents and encapsulation efficiency were reduced as tem-
perature increased. At 50 C and 60 C, the drug-loading con-
tents were below 3.5% and encapsulation efficiencies were
below 73%. This was probably caused by the degradation of
DOX or P5kSSLV copolymer at higher temperature. Compared
with 25 C, nanomicelles at 37 C had higher drug-loadingFig. 6 e The particle size changes of P5kSSLV-DOX
nanomicelle with different dilution factor.
Fig. 7 e The particle size changes of P5kSSLV-DOX
nanomicelle during 1 month storage at 4 C.
Fig. 8 e The zeta potential changes of P5kSSLV-DOX
nanomicelle during 1 month storage at 4 C.
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loading content and encapsulation efficiency increased with
the extension of hydration time. After 5 h, drug-loading con-
tent and encapsulation efficiency remained relatively stable. It
indicated that the DOX had come into the P5kSSLV nano-
micelles as more as possible and the system had been stable.
Therefore, 37 C and 5 hwere chosen as the optimal hydration
temperature and hydration time.
3.3.3. Weight ratio of P5kSSLV to DOX
The amount of P5kSSLV copolymer was fixed at 20 mg, and
different doses of DOX were added into the organic solvent to
achieve different proportions between P5kSSLV and DOX
(20:0.5, 20:1, 20:2, 20:3, w/w). Table 2 showed the particle sizes
of different proportions were similar, suggesting that the
amount of DOX had minimal effect on the particle size. This
might be due to the strong hydrophobic interaction between
DOX and di-tocopherol succinate. All the zeta potential values
werenear zero.Thiswasbecause thePEGchain formedneutral
PEG hydration shell on the surface of nanomicelle, whichFig. 9 e The drug-loading content changes of P5kSSLV-DOX
nanomicelle during 1 month storage at 4 C.would reduce the electronegativity of nanomicelles. The
encapsulation efficiency of nanomicelle decreased as the
dosageofDOXincreased.Theencapsulationefficiencyat20:0.5
(97.31±1.15)wasclose to thatof20:1 (97.20±1.02), but thedrug-
loading content was much higher at 20:1. Therefore, 20:1 was
used as the optimum proportion between P5kSSLV and DOX.
3.3.4. Cryoprotectant
For long-term storage, it is ideal for P5kSSLV-DOX nano-
micelles to be freeze-dried. Particle size was measured after
different cryoprotectants was used to reflect the quality of
freeze-drying procedure. As shown in Table 3, no cryopro-
tectant and mannitol yielded much bigger particle size than
sucrose. The relatively smaller particle size after freeze-drying
with sucrose was much closer to the particle size before
lyophilization, which reflected a better quality of cryoprotec-
tant. Therefore, 5% sucrose was chosen as the cryoprotectant.
In summary, the optimal preparation method was deter-
mined as follows: P5kSSLV-DOX nanomicelle was prepared
with thin-film hydration method; dichloromethane was cho-
sen as the organic solvent; the hydration temperature and
time were 37 C and 5 h, respectively; the proportion of
P5kSSLV and DOX was 20:1 (w/w), with the cryoprotectant
being 5% sucrose.
3.4. Particle morphology
The particle morphology of P5kSSLV-DOX nanomicelle was
investigated with TEM. Fig. 5 showed the nanomicelles were
spherical with relatively homogeneous size distribution
around 14e21 nm in diameter.
3.5. Stability study of nanomicelle
P5kSSLV has a low CMC value, which can self-assemble into
nanomicelles easily and maintain the structural integrity. To
examine the dilution stability, P5kSSLV-DOX nanomicelles
solution was diluted with double distilled water, and the
particle size was measured. As shown in Fig. 6, the particle
size was about 30 nm within 100 times dilution. Then the size
increased to 78.21 nm at 1000 times dilution and 104.6 nm atFig. 10 e The encapsulation efficiency changes of P5kSSLV-
DOX nanomicelle during 1 month storage at 4 C.
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micelle was on the verge of disassemble, but still maintained
the basic structure of micelle. The results indicated P5kSSLV-
DOX nanomicelles had high dilution stability.
We further investigated the storage stability of P5kSSLV-
DOX nanomicelle during 1 month of storage at 4 C Figs. 7e10
showed the particle size, zeta potential, drug-loading content
and encapsulation efficiency had little change during the one-
month period, which suggested that P5kSSLV-DOX nano-
micelle had a high storage stability at 4 C storage. This was
due to hydrophilic PEG chain increasing the dispersity of the
nanomicelles in water and preventing the aggregation be-
tween nanomicelles.4. Conclusions
A redox-responsive P5kSSLV-DOX nanomicelle was prepared
with thin-film hydration method. The dosage of DOX, type of
organic solvent, hydration temperature and time, and cryo-
protectant were investigated to optimize the preparation
method. The prepared nanomicelle has small particle size,
uniform size distribution and high encapsulation efficiency
of DOX. In addition, P5kSSLV-DOX nanomicelle has high
dilution stability and storage stability. Taken together, thin-
film hydration method was an ideal method to prepareP5kSSLV-DOX nanomicelle that could maintain a long-term
stability.r e f e r e n c e s
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